By Sarah Calkin2013-11-21T12:00:00
Source: Sebastian Kaulitzki
Cancer patients who were denied access to a cutting edge therapy under NHS England’s specialised commissioning policies will be able to access it again if they agree to take part in a clinical trial.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud